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Abstract
It has been suggested that the rate of queuine uptake ;nto cultured human fibroblasts is controlled by phosphorylation levels within the
cell. We show that the uptake of queuine is stimulated by activators of protein kinase C (PKC) and inhibitors of protein phosphatase:
while inhibitors of PKC. and down-regulation of PKC by chronic exposure to phorbol esters inhibit the uptake of queuine into cultured
human fibroblasts. Activators of cAMP- and cGMP-dependent kinases exert no effect on the uptake of queuine into fibroblast cell
cultures. These studies suggest that PKC directly supports the activity of the queuine uptake mechanism, and that protein phosphatase
activity in the cell acts to reverse this. Regardless of the modulation of uptake rate. the level of intracellular queuine base saturates in 6 h.
However. there is still an effect on the incorporation rate of queuine into tRNA of fibroblast cultures even after 24 h. We now show that
the incorporation of queuine into tRNA in cultured human fibroblasts by tRNA-guanine ribosyltransferase (TGRase) is also stimulated by
activators of PKC and inhibitors of protein phosphatase: while inhibitor.,+ of PKC decrease the activity of this enzyme. These studies
suggest that PKC supports both the cellular transport of queuine and the activity of TGRase in cultured human fibroblasts, and that
protein phosplzatasc activity in fi',;roblasts acts to reverse this phe~tomenon. A kinase-phosphatase control system, that is common to
controlling both inm~cellular ~i,gnal transduction and many enzyme systems, appears to be controlling the availability of the queuine
substrate and the mechanism lk)r its incorporation into tRNA. Since hypomodification of transfer RNA with queuine is commonly
observed iu undift~'rentiated, rapidly growing and neoplastically transformed cells, phosphorylation of the queuine modification system
may be a critical regulatory mechanism for the modification of tRNA and subsequent control of cell growth and differentiation.
Keywords: Queuine; Protein kinase C: Protein phosphatase

1. Introduction
There are a large number of modified nucleosides found
in tRNA molecules. Various individual modifications have
been suggested to play important roles in molecular biology. One example is the queuosine modification of tRNA.
The pro-formed base, queuine, is incorporated into tRNA
as an irreversible post-transcriptional exchange for guanine
in the first position of the anticodon of four fftNA isoacceptors (Asp. Ash. His and Tyr) to generate the nucleoside
queuosine. The unique base exchange :eaction is catalyzed
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by the enzyme tRNA-guanine ribosyltransferase (TGRase)
(EC 2.4.2.29) [ I - 4 ] .
Research concerning the function o f qveuosine-modified tRNA indicates it may be a controlling agent in the
differentiation, development, and stress mana,~ement o f
several cell types. Alterations in the levels of queuosinemodified tRNA have been observed during differentiation
and development for D. discoideum [5], plants [6],
Drosophila [7-9], as well as development and aging in the
rat [10]. Queuosine-modified tRNA in Escherichia coli
protects the organism from stress induced by suboptimal
growth conditions [1 I]. Queuosine-modified tRNA also is
involved with lactate dellydrogenase and cytochrome b-559
expression in mammalian systems, and therefore may be
involved with management of oxidative stress in eukaryotic cells [12-14]. The presence of the queuine base has
been proposed to have effects on controlling protein synthesis [!5], as well as aspects of protein phosphorylation
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[15], and regulation of cell signaling by receptor tyrosine
kinases [16]. Therefore. the queuine base and queuosinemodified tRNA appear to exert important controlling effects on cellular physiology.
Transfer RNA isolated from neoplastic tissues and
transformed cell lines is hypomodified with queuosine to
various degrees [2.17.18]. The degree of hypomodification
is related to the severity or malignancy of disease in
human !ymphomas, leukemias [19], lung cancers [20], and
ovarian carcinomas [21]. Murine erythroleukemia cells are
also typically queuosine-deficient, rhese cells can be forced
to differentiate and have been saown to demonstrate a
signifcant concurrent increase in tRNA queuosine levels
[22,23]. The differentiation of these cells and the queuosine-level increase was blocked effectively by chronic
treatment with the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA) [22]. These observatior.s
suggest that hypomodification of tRNA with queuosine is
related to growth enhancing or tumor promoting events.
Chronic exposure of cultured normal human fibroblasts
to phorbol- 12.13-didecanoate (PDD) induces a large inhibition of the queuosine modification of tRNA [24]. The
decrease in queuosine content of tRNA precedes an increase in the population density of the fibroblast cultures.
Concurrent addition of purified queuine effectively blocks
the population density increase in fibroblast cultures chronically exposed to PDD. and maintains :.he queuo:dne level
in those cells at near normal levels. These data imply that
the free queuine base or the queuosine modification of
tRNA is related to a controlled growth rate in normal
human fibroblasts.
Mammals are incapable of synthesizing their own
queuine, and therefore must obtain it from their diet or gut
flora [25,26]. Mammalian cells grown in culture obtain
queuine from animal serum used to supplement their growth
media [3,26]. This suggests that efficient cellular uptake of
dietary queuine across the cell membrane is a prerequisite
to the insertion of the base into tRNA by TGRase. It was
demonstrated that cellular uptake of queuine may be sensitive to phorbol esters [27.28], and it was suggested that
queuine uptake may be modulated by protein kinase C
(PKC) [29]. Chronic exposure of cultured cells to pborbol
esters has been shown to induce a proteo!ytic down-regulation of PKC and its activity [30]. Sittce we observed a
decrease in the level of queuosine-modified tRNA with
chronic exposure of human fibroblasts to PDD [28]. it is
proposed that the down-regulation of PKC activity levels
in the cell cultures may be decreasing the activity of the
mechanism for the formation of queuosine-modified tRNA.
Evidence presented in this manuscript demonstrates that
a PKC-protein phosphatase system is important tbr maintenance of queuine uptake rates. The phosphorylation level
of the queuine uptake mechanism in cultured human fibroblasts is proposed to modulate the baseline activity for
queuine uptake into cultured normal human fbroblasts.
However, the profound level of queuosine-hypomodifica-
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tion obser',cd in tRNA after chronic exposure to PDD
argues agaim, t substrate limitation as a sole mediating
influence, since queuine still gets into the cell to a saturable level by 6 h. albeit at a modestly reduced rate. Our
results suggest that a PKC-protein phosphatase system is
also important for maintenance of the TGRase activity
level in cultured cells. The level of phosphorylation of
both the queuine uptake mechanism and the incorporation
enzyme (TGRase) in cultured human fibroblasts modulates
the baseline activity for the formation of the queuosine
modification in the anticodon of four tRNAs.

2. Materials and methoqJs
2. I. Cell culture

Cell culture:, were established and maintained in neonatal calf serum supplemented minimum essential media
(GIBCO, Grand Island NY) as previously described [2-4,].
Queuine-deficient fbroblast cultures for the queuine incorporation studies were generated by growing the cells in
media supplemented with 10% charcoal stripped calf serum
[24], for at least three passages before the studies were
initiated.
The addition of a radiolabelled analog of queuine.
tri-tritiated dihydr,~ueuine (rQT3), to cell cultures was
employed to monitor cellular uptake of this base and its
incorporation into tRNA. This agent was obtained as a gift
from Dr. Ronald W. Trewyn (Kansas State University).
The rQT~ substrate was prepared by dissolving lyophilized
rQT 3 in water to yield a stock concentration of I mM with
a specific activity of 0.t9 btCi//.tg and stored at -20°C.
cGMP- and cAMP-dependent kinase, and PKC activators were obtained from Sigma Chemicals (St. Louis. MO).
The cGMP and cAMP analogues (dibutyryl and 8-brom¢,;
were applied to cell cultures at a concentration of 10/,tM.
12-tetradecanoyl phorbol- 13-acetate (TPA) and phorbol12,13-didecanoate (PDD) were used at concentrations of
20 riM. The PKC inhibitors sphingosine (used at 20 /.tM),
staurosporine (used at 100 riM), and calpbostin C (used at
100 nM) were purchased from Biomol Research Laboratories of Plymouth Meeting, PA. The PKC inhibitor H-7
(I-(5-isoquinoline sulfonyl)-2-methyl piperazine dihydrochloride) (utilized at 10 /.tM) was obtained from Seikagaku America (St. Petersburg, FL). The protein phosphatase inhibitors okadaic acid and calyculin A (utilized at
varying nM concentrations) were purchased from Biomol
Research Laboratories. All culture work was pertbrmed in
sterile polystyrene plasticware from Coming.
2.2. Assay fi,r rQ'~r~ uptake imo cells

Fibroblasts were subcultured into 35-ram dishes at a
density of 4 × 10~ cells/ml in a final volume of 2 ml of
media containing 10% serum. When the cells reached
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I m! of media supplemented with 10% charcoal stripped
calf serum and 100 nM rQT 3 ( 0 . 1 0 / x C i ) was added to the
cultures. Incorporation of rQT3 into the acid precipitable
fraction (tRNA) of control cultures was compared to cultures treated with kinase activators or inhibitors and protein phosphatase inhibitors. PKC and protein phosphatase
inhil,itors were added to the cultures at the same time as
rQT 3 for short-term studies, or 7 days prior to the addition
of rQT 3 for chronic exposure studies. Incubations for rQT 3
incorporation analysis were conducted at 37°C for timed
intervals of up to 12 h. Incubations were terminated by
rinsing the cell monolayer four times with 5 ml of ice-cold
phosphate-buffered saline, followed by disruption of the
cells with 0.5 ml o f lysis buffer (10 mM Tris (pH 7.5),
0.01% SDS, 0.01% Triton X-100) for I0 min at room
temperature. The lysate was transferred to a small test tube
and treated with 0.25 ml of ice-cold 30% trichloroacetic
~, :id (TCA). The lysate was placed on ice for 10 min and
the resulting precipitate was collected by v a c u u m aspiration through G F A 2.4 cm glass fiber filter disks. Each disk
was thoroughly rinsed with 40 ml o f ice-cold 5% T C A and
a final rinse of 5 ml ice-cold 95% ethanol. The filters were
analyzed for bound radioactivity by liquid scintillation,
The level of radioactivity on the filter disks was reflective
o f rQT 3 incorporation into the acid precipitable fraction
(tRNA) from cultured fibroblast cells.

confluence, the media was decanted and I ml of media
supplemented with 10% calf serum and 100 nM rQT 3
(0.10 ,ttCi) was added to the cultures. Uptake of rQT 3 into
untreated control cultures was compared to cultures treated
with kinase or protein phosphatase modulating agents at
concentrations as stated above. For short-term exposure
studies, PKC and protein phosphatase inhibition agents
were added to the culture at the same time as the rQT 3
substrate. For chronic exposure stt~dic:~, the agents were
introduced to the cell growth media and exposed to the
cells for seven days prior to the introduction o f rQT 3.
Incubations for rQT 3 uptake analysis were conducted at
37°C for up to 4 h and terminated by rinsing the cell
monolayer four times with 5 ml of ice-cold phosphatebuffered saline, followed by cell lysis with 1.0 ml of 95%
ethanol for 5 min. The lysate was aspirated and radioactivity determined by liquid scintillation. The level of radioactivity in the cell lysate is reflective o f rQT 3 uptake into the
cultured cells.
2.3. A s s a y f o r rQT~ #tcorporation into tRNA

Fibroblasts were subcultured into 3 5 - m m dishes at a
density of 4 × l0 "~ c e l l s / m l in a final volume of 2 ml of
media containing 10% charcoal stripped calf serum. When
the cells reached confluence, the media was decanted and
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and H-7). as well as phosphatase inhibitors (okadaic acid
and calyculin A) were studied to establish and verify
phosphorylation as the control m e c h a n i s m for queuine
uptake.
Cultured h u m a n flbroblasts (passages 3 - 5 ) were exposed to these agents to discern influences on r Q T 3 uptake
after a 3-h incubation (Fig. 1). T h e agents that are reported
to stimulate the c A M P - or c G M P - d e p e n d e n t kinase systems had no effect on the rate o f r Q T 3 uptake. H o w e v e r ,
stimulators o f PKC increased the rate of r Q T 3 uptake by
50% when c o m p a r e d to untreated controls. By contrast,
cellular exposure to inhibitors of P K C all decreased the
rate o f rQT~ uptake. Additional fibroblast cultures were
exposed to the protein phosphatase inhibitors in order to
maintain higher protein phosphorylation levels within the
cell. These cultures s h o w e d a similar increase in queuine

3. R e s u l t s

3,1. Regulation o f the queuine uptake mechanism
D u e to the reported sensitivity o f queuine uptake to
phorbol esters [28.29], it was suggested that this system
m i g h t be activated by PKC-catalyzed phosphorylatiotL In
this study, several kinase and phosphatase modulators were
used to identify the specific kinase and phosphatase families i n v o l v e d in the regulation o f the queuosine modification system. Activators for c A M P - d e p e n d e n t protein kinase ( b u t y r y l - c A M P and 8 - b r o m o - c A M P ) , c G M P - d e p e n dant protein kinase ( b u t y r y l - c G M P and 8 - b r o m o - c G M P ) .
and P K C ( T P A and P D D ) were e m p l o y e d to identify the
participating kinase family. P K C activators ( T P A and PDD)
and inhibitors (calphostin C, sphingosioe, staaurosporine,
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uptake when compared to those treated with PKC activators. further suggesting that phosphorylation is involved in
the regulation of queuine lransport.
Parallel time course studies of rQY~ uptake with shortterm treatment to staurosporine, calphostin C. TPA. calyculin A. and okadaic acid were performed and compared to
the rQT.~ uptake rate in control cells at hourly intervals
over 4 h. Exposure to the PKC inhibitors resulted in a
decrease in the uptake rate for rQT s as compared to
untreated control fibroblast cultures (Fig. 2a). The PKC
activator (TPA) nearly doubled the rate of rQT~ uptake.
while the protein phosphatase inhibitors also stimulated the
rQT 3 uptake rate (Fig. 2b). This further indicates that
queuine uptake efficiency is linked to protein phosphorylation levels.
Fibroblast cultures were pre-treated for 7 days with
TPA. staurosporine, and okadaic acid in order to measure
effects of long-term exposure to these modulators on
queuine uptake (Fig. 2c). This is particularly revealing
since chronic exposure to TPA results in proteolytic
down-regulation of PKC activity [30]. As expected, exposures to the PKC inhibitor significantly decreased the
uptake of queuine at 3 h of exposure to rQT 3. while
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The relatively high concentrations of the protein phosphatase inhibitors used in the short-term exposure study
was cause for concern given their reported toxicity levels
[31-33]. A range of concentrations of calyculin A and
okadaic acid were studied to analyze their effects on the
3-h time point for rQT 3 uptake relative to untreated control
fibroblast cultures (Fig. 3). These studies were performed
for both short-term (simultaneous exposure to inhibitor and
rQT 3) and for chronic exposure to the inhibitors (pre-treatmerit: 7 days prior to addition of rQT3).
Concentrations of okadaic acid in excess of 100 nM
proved to be cytotoxic for the 3-h short-term exposure
studies. However, increasing concentrations of okadaic
acid from 5 to 100 nM demonstrated progressively increas-
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protein phosphatases of the type I group are participating
in the modulation of rQT 3 uptake in human fibroblasls.

ing rQT 3 uptake (Fig. 3a). Similar trends were observed in
studies of chronic exposure to this phosphatase inhibitor
(Fig. 3b). Increasing concentrations of okadaic acid from I
to 10 nM demonstrated progressively increasing rQT3 uptake rates, while concentrations over 10 nM were cytotoxic
to the fibroblast cultures. Comparable results were seen
with studies using the protein phosphatase inhibitor calyculin A. However, the fibroblast cultures were much more
sensitive to this compound. Exposure for 3 h to 1 nM
calyculin A effectively increased the rate of rQT~ uptake
(Fig. 3c). For chronic exposure (7 day pre-treatment), 0.2
nM calyculin A demonstrated equivalent maximal induction of rOT3 uptake rate (Fig. 3d). Concentrations above
these levels were cytotoxic in both short-term and chronic
exposure studies, respectively.
it has been reported that calyculin A is a more effective
inhibitor of protein phosphatase 1 than okadaic acid. In one
study, IC50 values of approx. 50 nM for okadaic acid and
0.3 nM for calyculin A were reported for muscle phosphatase I [31]. Based on the reported sensitivity of protein
phosphatases type I and 1I to okadaic acid and calyculin A
with pre-treatment exposure [31-33], our data suggest that

3.2. Regulation t~f the queuine incorporatirm rnechanisrn

Ahhough tl-e rate of uptake can be modulated, it was
observed that maximal uptake of the queuine base to a
saturating level occurs in 6 h (unpublished data). After this
point, uptake and efflux are balanced [27]. Thus, the
modulation of the uptake mechanism might not be solely
responsible tk)~ the dramatic queuosine-modification deficiency seen in neoplastic transformation and progression
of cancer cells to metastasis. Thus, the queuine incorporation mechanism (TGRase) was studied to determine if
PKC acts in a dual role in modulating both components of
the queuine modification system.
First, cultured human fibroblasts (passages 3 - 5 ) were
exposed to dibutyryl and 8-bromo analogs of cAMP and
cGMP. as well as TPA, PDD, calphostin C. sphingosine,
staurosporine. H-7. okadaic acid or calyculin A for up to
12 h in order to determine effects on the incorporation of
rQT, into tRNA by TGRase (Fig. 4). The queuine incorpo-
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cells treated with 10 ~tM 7-methylguanine.a competitiveinhibitor for the incorporation enzyme TGRase. This also helps to verify the minimal level of
incorporation activity in this study. Remaining bars represent rQT~ incorporation into the tRNA of cultures exposed to various kinase and phosphatase
modulators for 8 h at concentrations of 10 /xM for dibutyryl-cGMP. 8-bromo-cGMP. l0 .v.Mdibut}ryl-cAMPand 8-bromo-cAMP.20 nM for TPA and
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incorporation of radiolabelledqueuine into tRNA in all cultures (4 × l0 ~ cells) was measuredafter a 37°C incubation with 100 nM rQTt and modulatorsat
8 h. These values were normalizedto number of pmol rQT~ incorporated into the acid-precipitable fraction of l0 ~ cells. The "untreated"bar represents
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cultures' values into percentage. Deviationbars indicated represent the standard deviation ~ith n = b.
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ration rates of cells exposed to these modulators were
c o m p a r e d to an untreated control culture and three additional control (positive and negative) cultures. These additional control fibroblast cultures were utilized to establish
both the m a x i m u m and m i n i m u m incorporation linrits for
comparison to the experimental sample
Fibroblasts deficient in queuosine-modified t R N A were
established in queuine-deficient m e d i a supplemented with
charcoal-stripped serum. Cells g r o w n under these conditions for three passages are completely deficient in queuesine-modified t R N A (unpublished data). Queuosine-deficient t R N A cultures were used as substrate targets for
demonstrating the m a x i m a l incorporation rate of r Q T 3 into
t R N A by T G R a s e (positive control). These cells d e m o n strated a nearly two-fold increase in r Q T 3 incorporation
rate w h e n c o m p a r e d to normal s e r u m - s u p p l e m e n t e d con-

~o,6

~5

trois. The slower rate o f incorporation in serum-supplem e n t e d control cells is likely due to partial queuosinemodification o f the existing t R N A population in the cell.
T w o negative control cultures were g r o w n in 10% serumsupplemented media. O n e culture was treated with additional 100 nM queuine and the other was treated with 10
/.tM 7-methylguanine. Addition o f excess queuine c o m pletely and irreversibly saturates the cell's t R N A with
queuosine and eliminates the cell's t R N A as a substrate for
r Q T 3 incorporation. 7-Meiltylg,,anine is a c o m p e t i t i v e inhibitor of T G R a s e and blocks the ability o f T G R a s e to
incorporate r Q T 3 into t R N A at concentrations used here
[34]. These two cultures both represent the b a c k g r o u n d
levels of non-specific rQT3 association to the acid precipitable fraction o f solubilized cell cultures, which is expected with the absence o f T G R a s e activity.
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Fig. 5. The effect of protein kinase C and protein phosphatase modulators on queuine incorporation into tRNA in human fibroblasts. Graph 5a) displays the
incorporation of rQT3 into IRNA during short-term exposure of cultures to protein kinase C inhibitors. The top line ( + ) represents incorporation of rQT3
into acid-precipitable fractions of untreated control cultures: the lower line~ represent values for culture!; treated with 100 nM calphostin C (O), 100 nM
staurosporine ( • ) . and 20 /.tM sphingosinc ( • ) . respectively. Graph 5b illustrates the incorporation of rQT3 into tRNA during short-term exposure of
cultures to protein kinase C activators and protein phosphatase inhibitors. The bottom line ( + ) represents incorporation of rQT3 into tRNA of untreated
comrol cultures: the upper lines represent cultures treated with 10 nM oki~daic acid ('¢'), 20 nM TPA (O), and 0.2 nM calyculin A (O). respectively. In
these short-term exposure studies, modulators were added to cultures at time 0. Graph 5c show:~ the incorporation of rQT:~ into tRNA during chronic
exposure of cultures to the modulators. The traces represent the rate of rQT~ incorporation into the tRNA of untreated control cultures t + ) and those
pre-treated for 7 days to 20 nM TPA ( C3). 10 nM okaduic acid (¢'), and 100 nM staurosporine ( • ) . The incorporation of radiolabelled queuine into tRNA
in all cultures (4 × 105 cells) was measured after a 37°C incubation with 100 nM rQT at O. 3.6. 9 and 12 h. These values were normalized to number of
pmol rQT~ incorporated into the acid-precipitable fraction of 105 cells. Deviation bars indicated represent the standard deviation with n = 4.
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Cell cultures treated with agents that increase the aclivity of cAMP- and cGMP-dependent kinases appear to
have no effect on the incorporation rate of rQT3 (Fig. 4).
However, PKC activa',ors and phosphatase inhibitors increase the incorporation of rQT3 toward that observed in
totally queuosine-deficient cells. While cells treated with
inhibitors of PKC reduce the incorporation of rQT~ to a
t,aseline level just above that of non-specific binding. This
further demonstrates that PKC-catalyzed phosphorylation
is important in cegulation of TGRase activity, thus the
formation of the queuosine modification of tRNA.
Next, a 12-h time course for rQT3 incorporation into
tRNA of queuosine-deficient tRNA fibroblast cultures was
performed in cells grown for three passages in 10c~ charcoal-stripped serum (queuine-free) supplemented media
(Fig. 5a,b). In short-term exposure studies, rQT3 and various modulating agents (staurosporine, sphingosine,
calphostin C, TPA, okadaic acid and calyculin A) were
simultaneously added to parallel cultures. Then. these were
analyzed for rQT3 incorporation into tRNA at 4-h intervals
for 12 h. lnhibitors of PKC decreased the rate of rQT3
incorporation into tRNA to a baseline level as compared to
untreated controls (Fig. 5a). The protein kinase activator
and phosphatase inhibitor, when added to cell cultures at
the same time as rQT3, both increased the rQT3 incorporation rates when compared to untreated control cells (Fig.
5b). Queuosine-deficient cells pre-treated with various
agents for 7 days were studied for rQT3 incorporation rates
into tRNA over a 12-h time course (Fig. 5c). Chronic
exposure to TPA, which induces a proteolytic down-regulation of PKC [30], resulted in a decrease in rQT 3 incorporation into tRNA. However, treatment with staurosporine
was more effective at inhibiting the rate of rQT3 incorporation in cell cultures. It is both possible and likely that
residual PKC activity may still be present in the cells
chronically exposed to TPA.
Chronic pre-treatment of these cells for 7 days with
okadaic acid showed rQT3 incorporation levels lower titan
that of the control. Since this treatment maintains the
phosphorylation level in the cell, the activity of TGRase
should be enhanced d,Jring this preparative step. TGRase
would effectively recycle queuine from tRNA turnover and
incorporate it into new transcripts of tRNA. At the time of
the rQT3 addition, the cognate tRNA would be saturated
with the queuosine modification and would no longer be
used as a substrate for incoming rQT3 due to the irreversible nature of the queuine incorporation reaction.
Therefore, chronic exposure to okadaic acid should actually decrease the rate of rQT3 incorporation into tRNA as
compared to control cultures, and this is indeed the case
(Fig. 5c).
4. Discussion
The uptake of queuine into human fibroblasts appears to
be modulated by phosphorylation. Activators of cAMP and
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cGMP dependeot kinases have no effect on rQT3 uptake.
However, increasing PKC activity with phorbol ester treatment elevates the rate of rQT3 uptake. Conversely, chronic
exposure of TPA to fibroblast cultures, which is known to
down-regulate PKC activity, decreases rQT3 uptake. A
spectrum of protein kinase inhibitors, with various specificities to PKC. all inhibit rQT3 uptake into fibroblast
cultures in concentration ranges reported to be most specific for PKC. These results make a strong case for the role
of PKC in enhancing the uptake rate of queuine into
fibroblast cultures.
The inhibition of protein phosphatases by both okadaic
acid and calyculin A also induces an increase in the uptake
of rQT,. These results indicate that maintenance of protein
phosphorylation is important to maximize the rate of
queuine uptake. Due to the concentrations of the two
phosphatase inhibitors involved, it is likely that protein
phosphatases of type ! are down-regulating queuine uptake
activity by removing a phosphate group from the queuinespecific membrane transporter. This analysis is based on
reported sensitivity of protein phosphatases type 1 and It to
okadaic acid and calyculin A [31-33].
TGRase activity in cultured human fibroblasts also
appears to be modulated by PKC and protein phosphatase
activity. Activators of cAMP- and cGMP-dependent kinases have no effect on rQT3 incorporation. However,
activators of PKC and inhibitors of protein phosphatase
both increase TGRase incorporation rates above a baseline
incorporation level, while inhibitors of PKC decrease incorporation rates of rQT 3 to the baseline level. Chronic
exposure to TPA, which is known to induce a proteolytic
down-regulation of PKC, also decreases rQT3 incorporation into fibroblast tRNA when compared to untreated
controls. These results make a strong case for the role of
PKC in enhancing the incorporation rate of queuine into
tRNA in fibroblast cultures. Furthermore, supporting evidence recently published by this laboratory demonstrates
direct phosphorylation and activation of purified rat liver
TGRase by PKC in vitro [35]. This indicates that control of
TGRase activity by phosphorylation may be a universal
mammalian phenomenon.
We propose that PKC and protein phosphatase are
important modulators of both queuine uptake and incorporation into tRNA in cultured human fibroblasts. These are
likely to be independently regulated sites for PKC due to
(I) the ability of the uptake mechanism to fully saturate
the cell with queuine in 6 h despite down-regulation by
dephosphorylation, (2) the observation of the modulation
of TGRase activity up to 24 h, and (3) the in vitro
evidence that shows direct phosphorylation and regulation
of rat liver TGRase activity by PKC [35].
PKC activity stimulates queuine uptake and incorporation rates, while competing phosphatase activity reduces
these to a baseline level. Kinase-phosphatase control systems are important components of the cell's signal transduction system, and are known to be critical components
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involved with differentiation, control o f cell g r o w t h and
neoplastic translormation. T h i s w o r k ties an important
signal transduction n e t w o r k to m e c h a n i s m s responsible for
t R N A modification with qucuinc. Alterations in the signal
transduction s y s t e m can effect both the availability o f
queuine base and the activity o f T G R a s e which can potentially lead to the q u e u o s i n e - h y p o m o d i f i c a t i o n o f t R N A
c o m m o n l y o b s e r v e d in netJplastically t r a n s f o r m e d and undifferentiated cells.
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